nodepositpoker| Puli Pharmaceutical: Oseltamivir phosphate capsules obtained marketing authorization

News summary

Puli Pharmaceutical: Oseltamivir Phosphate Capsules Obtained Marketing Approval Securities Times e Company Newsnodepositpoker, Puli Pharmaceutical (300630) announced on the evening of April 23nodepositpoker, the company recently received a Class 4 chemical marketing authorization issued by the State Food and Drug Administration for oseltamivir phosphate capsules. The drug can be used in adults and adults aged 13 and 13nodepositpoker.nodepositpoker..

Newsletter text

Puli Pharmaceuticals: Oseltamivir Phosphate Capsules Obtained Marketing Approval Securities Times Company e News, Puli Pharmaceuticals (300630) announced on the evening of April 23 that the company recently received a chemical product issued by the State Food and Drug Administration for oseltamivir Phosphate Capsules. Category 4 marketing authorization. This drug can be used for the prevention of influenza A and B in adults and young people aged 13 and over.